Your session is about to expire
← Back to Search
Behavioral Intervention
Digital Storytelling for Flu Vaccination in Children
N/A
Recruiting
Research Sponsored by Denver Health and Hospital Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to address the unequal impact of seasonal influenza on Black children by developing and testing a Digital Storytelling intervention to increase influenza vaccination rates in Black children aged 6 months to 5 years
Who is the study for?
This trial is for Black children aged 6 months to 5 years. The goal is to explore and test a new way of encouraging flu vaccinations through digital storytelling, aiming to reduce the gap in vaccination rates.
What is being tested?
The study is testing whether using digital stories can help increase flu vaccination rates among young Black children. It's an innovative approach that involves community engagement and could serve as a model for addressing similar health disparities.
What are the potential side effects?
Since this intervention uses digital storytelling rather than medical treatments, there are no direct physical side effects expected from participating in this trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Child influenza vaccination status at influenza season's end (defined as March 31, 2025 for season 1 and March 31, 2026 for season 2 if a 2nd season of recruitment is necessary)
Secondary study objectives
Intervention Acceptability
Intervention Appropriateness
Intervention Feasibility
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Digital storytelling groupExperimental Treatment1 Intervention
Caregivers will receive a series of digital stories by text message designed to increase influenza vaccine confidence.
Group II: Control groupActive Control1 Intervention
Caregivers will receive standard care.
Find a Location
Who is running the clinical trial?
Denver Health and Hospital AuthorityLead Sponsor
104 Previous Clinical Trials
401,920 Total Patients Enrolled